# Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD

> **NCT02386735** · NA · TERMINATED · sponsor: **Prof. Dr. Jörg Leuppi** · enrollment: 133 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Adverse Effect of Glucocorticoids and Synthetic Analogues
- Disease Exacerbation

## Interventions

- **DRUG:** Placebo
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT02386735
- **Lead sponsor:** Prof. Dr. Jörg Leuppi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 133 (ACTUAL)
- **Why stopped:** Low recruitment rate, motivation and engagement of participating GPs unfortunately declined over time, as well as the financial resources.
- **Last updated:** 2025-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02386735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02386735, "Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02386735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*